Abstract:Background Malignant melanoma is a leading cause of skin cancer‐related death. In over 30% of cases, the melanoma is invasive and has a metastatic phenotype. KCNQ1 overlapping transcript 1 (KCNQ1OT1) was previously identified as an oncogenic long noncoding RNA (lncRNA). Our study intends to uncover the mechanism of KCNQ1OT1 functioning in melanoma. Methods qRT‐PCR, immunohistochemical analysis, and Western blotting were used to investigate mechanisms of the lncRNA KCNQ1OT1, on its downstream genes in melanoma tissues, cells as well as the impact on CD8+ T cells. Proliferation, apoptosis, and migration/invasion were assessed in melanoma cells to evaluate the effects of KCNQ1OT1, miR‐34a, and signal transducer and activator of transcription 3 (STAT3). The RNA interactions were determined by dual‐luciferase reporter, and melanoma cells were co‐cultured with CD8+ T cells to study immune evasion. A lactate dehydrogenase (LDH) cytotoxicity assay was used to investigate the cytotoxicity of CD8+ T cells toward melanoma cells. The in vivo tumorigenic potential of KCNQ1OT1 was defined using xenograft models. Results KCNQ1OT1 was upregulated in melanoma tissues leading to a poor prognosis, and knocking down it inhibited melanoma cell proliferation, migration, and invasion. KCNQ1OT1 regulated the progression of the melanoma via its action as a miR‐34a sponge. STAT3 was found to be a downstream target of miR‐34a, resulting in transcriptional regulation of Programmed cell death 1 ligand 1 (PD‐L1). KCNQ1OT1 regulated STAT3 by targeting miR‐34a. Knockdown of KCNQ1OT1 reduced PD‐L1 level, enhanced CD8+ T cell cytotoxicity, and proliferation and inhibited apoptosis of CD8+ T cells. Conclusion Melanoma cells overexpressed KCNQ1OT1, which influenced the miR‐34a/STAT3 axis, to promote proliferation, migration, and invasion of melanoma cells. In addition, KCNQ1OT1 inhibited CD8+ T cell function, also via the miR‐34a/STAT3/PD‐L1 axis, thus promoting immune evasion of melanoma cells. The current findings expose a potential therapeutic target of melanoma.

Long noncoding RNA CPS1‐IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1

Silence of MACC1 Decreases Cell Migration and Invasion in Human Malignant Melanoma Through Inhibiting the EMT.

LINC00662 Promotes Melanoma Progression by Competitively Binding Mir-107 and Activating the Β-Catenin Signaling Pathway.

Expression of Breast Cancer Metastasis Suppressor-1, BRMS-1, in Human Breast Cancer and the Biological Impact of BRMS-1 on the Migration of Breast Cancer Cells.

A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5

BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway

The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer

KCNQ1OT1 sponges miR‐34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD‐L1 axis

[Progress on Breast Cancer Metastasis Suppressor 1 (BRMS1)].

Cyr61, a Member of CCN Family, is a Tumor Suppressor in Non-Small Cell Lung Cancer

Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma

LncRNA SLNCR1 facilitates angiogenesis and tumor growth in melanoma via DNMT1‐mediated epigenetically silencing SPRY2

The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis

Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells

BRD4L cooperates with MYC to block local tumor invasion via suppression of S100A10

Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses

BET Bromodomain Inhibition Potentiates Ocular Melanoma Therapy by Inducing Cell Cycle Arrest

Antisense Lncrna-Rp11-498c9.13 Promotes Bladder Cancer Progression by Enhancing Reactive Oxygen Species-Induced Mitophagy

RBPMS‐AS1 sponges miR‐19a‐3p to restrain cervical cancer cells via enhancing PLCL1‐mediated pyroptosis

Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β -catenin–c- myc –p53 pathway

EZH2-mediated Epigenetic Suppression of Long Noncoding RNA SPRY4-IT1 Promote S NSCLC Cell Proliferation and Metastasis by Affecting the Epithelial–mesenchymal Transition